Home › NDC Lookup › RxCUI directory › RxCUI 317094

Entacapone 200 MG Oral Tablet — RxCUI 317094

RxNorm drug concept · Semantic clinical drug
RxCUI 317094 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI317094
Official nameEntacapone 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped18
Reported Medicaid activity (SDUD)4,131 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Entacapone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It’s an add-on to levodopa and carbidopa for Parkinson’s disease. It helps when your symptoms return before your next dose, known as wearing-off. It doesn’t work on its own.
  • Take one tablet with each levodopa and carbidopa dose, as your prescriber directs. You can take it with or without food. Don’t stop it suddenly without talking to your doctor.
  • Common ones include extra or uncontrolled movements, nausea, diarrhea, stomach pain and dry mouth. Your urine may turn a darker color, which is expected. Let your doctor know if si...
  • Use caution. Some people on entacapone or levodopa have fallen asleep suddenly without warning, even while driving. If you’ve felt very sleepy or had a sudden sleep episode, avoid...
📖 Read our full Entacapone guide →

🕸️ Concept Web — How Entacapone 200 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Entacapone 200 MG Oral Tablet RxCUI 317094

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Entacapone 60307
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Comtan 262112
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Entacapone Oral Tablet 374616
    • Entacapone Oral Product 1161897
    • Entacapone Pill 1161898
    • Entacapone Oral Tablet [Comtan] 368216
    • Comtan Oral Product 1167429
    • Comtan Pill 1167430
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Entacapone 200 MG 330326
    • Entacapone 200 MG Oral Tablet [Comtan] 261318
    • Entacapone 200 MG [Comtan] 574540

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Entacapone 200 MG SCDC · 330326
  • Entacapone Oral Tablet SCDF · 374616
  • Entacapone Oral Product SCDG · 1161897
  • Entacapone Pill SCDG · 1161898

Brand-Name Concepts

  • Entacapone 200 MG Oral Tablet [Comtan] SBD · 261318
  • Entacapone 200 MG [Comtan] SBDC · 574540
  • Entacapone Oral Tablet [Comtan] SBDF · 368216
  • Comtan Oral Product SBDG · 1167429
  • Comtan Pill SBDG · 1167430
  • Comtan BN · 262112

📦 FDA Products & Package NDCs

14 products · 18 package NDCs
18 package NDCs map to RxCUI 317094 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00527-1830-37 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1830-37) Entacapone Lannett Company, Inc. 2018-12-20
00615-8298-39 30 TABLET in 1 BLISTER PACK (0615-8298-39) Entacapone NCS HealthCare of KY, LLC dba Vangard Labs 2019-07-01
00781-5578-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-5578-01) Entacapone Sandoz Inc 2014-06-04
00904-6822-07 30 BLISTER PACK in 1 CARTON (0904-6822-07) / 1 TABLET, FILM... Entacapone Major Pharmaceuticals 2024-05-02
27241-0049-10 100 TABLET in 1 BOTTLE (27241-049-10) Entacapone Ajanta Pharma USA Inc. 2017-08-31
33342-0260-11 100 TABLET in 1 BOTTLE (33342-260-11) Entacapone Macleods Pharmaceuticals Limited 2017-06-06
33342-0260-15 500 TABLET in 1 BOTTLE (33342-260-15) Entacapone Macleods Pharmaceuticals Limited 2017-06-06
46708-0478-31 100 TABLET, FILM COATED in 1 BOTTLE (46708-478-31) ENTACAPONE Alembic Pharmaceuticals Limited 2022-01-06
46708-0478-91 1000 TABLET, FILM COATED in 1 BOTTLE (46708-478-91) ENTACAPONE Alembic Pharmaceuticals Limited 2022-01-06
47335-0007-88 100 TABLET, FILM COATED in 1 BOTTLE (47335-007-88) Entacapone Sun Pharmaceutical Industries, Inc. 2013-04-01
50268-0295-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-295-15) / 1 TABL... Entacapone AvPAK 2016-12-05
60687-0188-21 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-188-21) / 1 TABL... Entacapone American Health Packaging 2016-06-02
62332-0478-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-478-31) ENTACAPONE Alembic Pharmaceuticals Inc. 2022-01-06
62332-0478-91 1000 TABLET, FILM COATED in 1 BOTTLE (62332-478-91) ENTACAPONE Alembic Pharmaceuticals Inc. 2022-01-06
64980-0722-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-722-01) Entacapone Rising Pharma Holdings, Inc. 2026-04-23
65862-0654-01 100 TABLET, FILM COATED in 1 BOTTLE (65862-654-01) Entacapone Aurobindo Pharma Limited 2015-06-19
65862-0654-99 1000 TABLET, FILM COATED in 1 BOTTLE (65862-654-99) Entacapone Aurobindo Pharma Limited 2015-06-19
71610-0247-83 3600 TABLET, FILM COATED in 1 BOTTLE (71610-247-83) Entacapone Aphena Pharma Solutions - Tennessee, LLC 2019-03-07
Observed labelers: Alembic Pharmaceuticals Inc. (2) · Alembic Pharmaceuticals Limited (2) · Aurobindo Pharma Limited (2) · Macleods Pharmaceuticals Limited (2) · Ajanta Pharma USA Inc. (1) · American Health Packaging (1) · +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.